• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

animas

Tandem looks to get in on ex-Animas customer base

October 25, 2017 By Sarah Faulkner

Tandem Diabetes

Tandem Diabetes Care (NSDQ:TNDM) and Dexcom (NSDQ:DXCM) announced yesterday that the companies would extend their existing joint welcome program aimed at luring Animas customers as Johnson & Johnson (NYSE:JNJ) bails out of the insulin pump biz. Tandem and Dexcom’s t:slim X2 welcome program was slated to end on Dec. 31, but the companies said yesterday that it would continue until […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: animas, DexCom Inc., johnsonandjohnson, Tandem Diabetes Care

Layoffs ahead for nearly 300 in Pennsylvania as J&J winds down Animas

October 23, 2017 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) plans to lay off nearly 300 workers in Pennsylvania as it winds down its Animas insulin pump business. The layoffs for 297 are slated for Animas operations in West Chester and Wayne, Pa., effective Dec. 15, according to a notice filed with the Commonwealth’s Dept. of Labor & Industry. J&J announced the […]

Filed Under: Diabetes, Featured Tagged With: animas, Johnson & Johnson

Insulet looks to lure Animas users

October 10, 2017 By Sarah Faulkner

Insulet Omnipod

Just days after Johnson & Johnson (NYSE:JNJ) revealed that it plans to shut down its 410-worker Animas insulin pump subsidiary, Insulet (NSDQ:PODD) said it would offer existing Animas insulin pump users a free trial of the company’s Omnipod system. Insulet’s Welcome Program includes a free Omnipod tubeless insulin delivery system, built-in blood glucose meter and 30 days […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: animas, Insulet, johnsonandjohnson, Medtronic

Johnson & Johnson to shutter Animas insulin pump biz

October 5, 2017 By Brad Perriello

Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) said today that it plans to shut down its 410-worker Animas insulin pump subsidiary, offering to help some 90,000 Animas patients transfer to products made by rival Medtronic (NYSE:MDT). The Chesterbrook, Pa.-based company said it will stop making its Animas Vibe and OneTouch Ping pumps, but will continue to provide customer […]

Filed Under: Diabetes, Featured, Wall Street Beat Tagged With: animas, johnsonandjohnson

Artificial pancreas: These companies are racing to make one

May 25, 2017 By Chris Newmarker

artificial pancreas TypeZero Tandem

Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at Drug Delivery Business’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out […]

Filed Under: Auto-injectors, Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health) Tagged With: admetsys, animas, artificialpancreas, Beta Bionics, Bigfoot Biomedical, defymed, DexCom Inc., Diabetes, Insulet, medtech, Medtronic, Semma Therapeutics, Tandem Diabetes Care, typezerotechnologies, universityofvirginia

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS